Rhinocerebral mucormycosis in a patient with pre‐B cell acute lymphoblastic leukaemia: PCR identifying Rhizopus oryzae from culture‐negative tissue specimens

References

1. Almyroudis N.G., Sutton D.A., Fothergill A.W., Rinaldi M.G., Kusne S. ( 2007). In vitro susceptibilities of 217 clinical isolates of Zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 51:2587–2590 [CrossRef]
   [Google Scholar]
2. Alvarez E., Sutton D.A., Cano J., Fothergill A.W., Stchigel A., Rinaldi M.G., Guarro J. ( 2009). Spectrum of Zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol 47:1650–1656 [CrossRef]
   [Google Scholar]
3. Muñoz‐Cadavid C., Rudd S., Zaki S.R., Patel M., Moser S.A., Brandt M.E., Gómez B.L. ( 2010). Improving molecular detection of fungal DNA in FFPE tissues: comparison of five tissue DNA extraction methods using panfungal PCR. J Clin Microbiol 48:2147–2153 [CrossRef]
   [Google Scholar]
4. Roden M.M., Zaoutis T.E., Buchanan W.L., Knudson T.A., Sarkisova T.A., Schaufele R.L., Sein M., Sein T., Chiou C.C. other authors( 2005). Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634–653 [CrossRef]
   [Google Scholar]
5. Spellberg B., Walsh T.J., Kontoyiannis D.P., Jr Edwards J., Ibrahim A.S. ( 2010). Recent advances in the management of mucormycosis: from bench to bedside. Curr Infect Dis Rep 12:423–429 [CrossRef]
   [Google Scholar]